205 related articles for article (PubMed ID: 21060664)
1. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign).
Chen E; Brown DM; Benz MS; Fish RH; Wong TP; Kim RY; Major JC
Clin Ophthalmol; 2010 Oct; 4():1151-8. PubMed ID: 21060664
[TBL] [Abstract][Full Text] [Related]
2. Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.
Stepien KE; Han DP; Schell J; Godara P; Rha J; Carroll J
Trans Am Ophthalmol Soc; 2009 Dec; 107():28-33. PubMed ID: 20126479
[TBL] [Abstract][Full Text] [Related]
3. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
4. Spectral-Domain Optical Coherence Tomography Is More Sensitive for Hydroxychloroquine-Related Structural Abnormalities Than Short-Wavelength and Near-Infrared Autofluorescence.
Jauregui R; Parmann R; Nuzbrokh Y; Tsang SH; Sparrow JR
Transl Vis Sci Technol; 2020 Aug; 9(9):8. PubMed ID: 32879764
[TBL] [Abstract][Full Text] [Related]
5. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.
Ahn SJ; Joung J; Lim HW; Lee BR
Am J Ophthalmol; 2017 Dec; 184():11-18. PubMed ID: 28964805
[TBL] [Abstract][Full Text] [Related]
6. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
de Sisternes L; Hu J; Rubin DL; Marmor MF
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
8. A possible early sign of hydroxychloroquine macular toxicity.
Brandao LM; Palmowski-Wolfe AM
Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
[TBL] [Abstract][Full Text] [Related]
9. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
10. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
11. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
[TBL] [Abstract][Full Text] [Related]
12. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
13. Early retinal and retinal nerve fiber layer effects of hydroxychloroquine: a follow up study by sdOCT.
Yülek F; Uğurlu N; Akçay E; Kocamış Sİ; Gerçeker S; Erten Ş; Midillioğlu İ; Şimşek Ş
Cutan Ocul Toxicol; 2013 Sep; 32(3):204-9. PubMed ID: 23351071
[TBL] [Abstract][Full Text] [Related]
14. [SD-OCT As screening test for hydroxychloroquine retinopathy: The «flying saucer» sign].
Asensio-Sánchez VM
Arch Soc Esp Oftalmol; 2015 Jul; 90(7):338-40. PubMed ID: 25443193
[TBL] [Abstract][Full Text] [Related]
15. Machine Learning-Based Automated Detection of Hydroxychloroquine Toxicity and Prediction of Future Toxicity Using Higher-Order OCT Biomarkers.
Kalra G; Talcott KE; Kaiser S; Ugwuegbu O; Hu M; Srivastava SK; Ehlers JP
Ophthalmol Retina; 2022 Dec; 6(12):1241-1252. PubMed ID: 35691579
[TBL] [Abstract][Full Text] [Related]
16. Signs of hydroxychloroquine toxicity in a patient with rhegmatogenous retinal detachment.
Campos-Pavón J; Sambricio J; Redondo-García I
Arch Soc Esp Oftalmol; 2016 Sep; 91(9):450-2. PubMed ID: 27005921
[TBL] [Abstract][Full Text] [Related]
17. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
Agarwal P; Wong YH; Dasgupta E; Agarwal R; Livingstone BI; Ramamurthy S; Chyn GS
Cutan Ocul Toxicol; 2015; 34(3):179-84. PubMed ID: 25068998
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of the new screening procedures for hydroxychloroquine retinopathy, according to the American Academy of Ophthalmology guidelines. Prospective study of 184 patients].
Jaumouillé S; Espargillière D; Mouriaux F; Mortemousque B
J Fr Ophtalmol; 2015 May; 38(5):377-87. PubMed ID: 25913441
[TBL] [Abstract][Full Text] [Related]
19. Macular ganglion cell-inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine.
Kan E; Yakar K; Demirag MD; Gok M
Int Ophthalmol; 2018 Aug; 38(4):1635-1640. PubMed ID: 28695378
[TBL] [Abstract][Full Text] [Related]
20. Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine.
Ulviye Y; Betul T; Nur TH; Selda C
Indian J Ophthalmol; 2013 Apr; 61(4):168-71. PubMed ID: 23685488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]